United BioSource Corporation offers patient access, safety, and evidence generation services for specialty therapies.
Founded in 2003 and headquartered in King of Prussia, US, United BioSource Corporation helps biopharma companies connect patients with specialty therapies through patient access, risk management, and real-world evidence services. It serves clients in oncology, rare disease, cell therapy, and gene therapy, mainly in North America and Europe. Avista Capital Partners acquired the company from Express Scripts Holding Company in December 2017. Dennis Mohamed is the founder.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in